Type 2 Diabetes Clinical Trial
Official title:
Post-extraction Wound Healing in Patients With Type 2 Diabetes
The purpose of this study is to evaluate clinical healing after dental extraction and the occurrence of surgical complications in patients with type 2 diabetes and compare with non-diabetic patients or control, taking into account laboratory data such as blood count, glycated hemoglobin (HbA1) and immunological profile of the patients.
It has been established in scientific literature that patients with diabetes have a greater
predisposition to oral complications and that oral infections may compromise their metabolic
control. There is scant clinical evidence of a relationship between diabetes and an
increased risk of infection after dental extractions. To our knowledge, no prospective
longitudinal studies have been designed to prove this hypothesis.
The aim of this study is to evaluate clinical healing after dental extraction and the
occurrence of surgical complications in patients with type 1 and 2 diabetes and compare with
non-diabetic patients, taking into account laboratory data such as blood count, glycated
hemoglobin (HbA1) and immunological profile of the patients.
Ninety patients shall be prospectively studied, divided into 3 groups: Group 1 will consist
of 30 patients with uncontrolled type 2 diabetics patients, group 2 will consist of 30
controlled type 2 diabetics patients and group 3 composed of 30 non-diabetic patients
(control group).
All patients will undergo extraction of erupted teeth, always carried out by the same
dentist (MS).
A complete medical history and laboratory tests will be conducted for all patients
including: glycated hemoglobin (HbA1), fasting glucose, complete blood count, platelets,
prothrombin time (PT), partial thromboplastin time (PTT), immunoglobulins (IgA, IgG and
IgM), CD3, CD4, CD8, testing of complement (C3, C4), dihydrorhodamine (DHR) oxidation,
phagocytosis index test and neutrophil chemotaxis.
At the end of surgery, blood pressure and plasma glucose by finger prick will be measured
again. Surgery characteristics will be recorded, such as: length of surgery time from
anesthesia to sutures, whether forceps and/or lever were used, the need to use a flap
approach, the number of vials of anesthetic used, and intra-ligament anesthesia.
The clinical assessment of healing will take place 3, 7, 21, and 60 days after surgery and
will be performed by the same dentist who perform the surgeries (KSF), blinded to the group
of the patient and laboratory exams. On these days, the region will be examined,
photographed and will be applied to the Visual Analogic Scale (VAS).
On day 60 after surgery, the postoperative period will be classified as: 1) no complications
or 2) with complications, according to Cheung et al 2001. The following situations will be
considered as complications after dental extraction:
1. Acute infection of the alveolus: pain, erythema, edema, purulent discharge and fever;
2. Acute inflammation of the alveolus: pain, inflamed alveolar tissue, absence of pus and
fever;
3. Dry socket: persistent pain and exposure of the alveolar bone.
All this clinical information will determine the post-operative quality regarding the
healing time and occurrence of infection and inflammation of the alveoli.
Data will be statistically analyzed in order for us to understand the pattern of healing and
occurrence of complications after dental extraction in the studied groups. The data analyzed
will include hematological data, immunological profile and the glycated hemoglobin of
patients.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |